Allisartan Isoproxil

阿利沙坦酯

Report date: 2025/06/18 10:56:25
NME

Base Information

Drug NameAllisartan Isoproxil
Drug Alias NameShun Li Tan艾力沙坦酯Xinlitan信立坦ALS-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryMainland China
Original Approved Date2013/10/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09CA
Related LinksN/A